Skip to main content

Advertisement

Log in

Resistance against broad-spectrum β-lactams among uropathogens in children

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the prevalence trends and risk factors for urinary tract infection (UTI) caused by Enterobacteriaceae resistant to broad-spectrum β-lactams in children. All Enterobacteriaceae uropathogens from children <15 years during the 11-year period 1997–2007 were included, and risk factors were evaluated. Of 523 Enterobacteriaceae isolated from 473 children, 30 (5.73%) were phenotypically resistant to broad-spectrum β-lactams (18 Escherichia coli, ten Klebsiella spp, one Enterobacter spp, and one Citrobacter spp). The prevalence of resistance increased during the study period (p = 0.031). Resistance to cefoxitin was common (26/30), pointing to AmpC enzyme expression, and 2/30 isolates were resistant to carbapenems. Resistant Enterobacteriaceae were often community acquired (22/30, 73.3%) and related to male gender (p < 0.05), urinary tract abnormalities (p < 0.05), prophylactic antibiotics (p < 0.0001), longer hospitalization (p < 0.001), and UTI recurrences (p < 0.001). Co-resistance was more likely for cotrimoxazole, gentamicin, and ciprofloxacin (p < 0.0001). In conclusion, our study points to increasing prevalence of Enterobacteriaceae uropathogens resistant to broad-spectrum β-lactams in the community setting, which limits the utility of first-line antibiotics and questions the validity of using prophylaxis after a first UTI episode.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315–317

    Article  CAS  Google Scholar 

  2. Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 33:1451–1456

    Article  CAS  Google Scholar 

  3. Jacoby GA (1997) Extended-spectrum beta-lactamases and other enzymes providing resistance to oxymino-beta-lactams. Infect Dis Clin North Am 11:875–887

    Article  CAS  Google Scholar 

  4. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 282:517–523

    Article  Google Scholar 

  5. Kim JY, Lautenbach E, Chu J, Goyal M, Nachamkin I, McGowan K, Coffin S, Zaoutis T (2008) Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species. Am J Infect Control 36:70–73

    Article  Google Scholar 

  6. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF (1999) Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 37:4065–4070

    Article  CAS  Google Scholar 

  7. Vranes J, Marijan T, Bedenic B, Mlinaric-Dzepina A, Katic S, Kalenic S (2008) Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region. Int J Antimicrob Agents 31:19S1–24S1

    Article  Google Scholar 

  8. Ena J, Arjona F, Martínez-Peinado C, López-Perezagua Mdel M, Amador C (2006) Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68:1169–1174

    Article  Google Scholar 

  9. Taneja N, Rao P, Arora J, Dogra A (2008) Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 127:85–88

    PubMed  Google Scholar 

  10. Gaspari RJ, Dickson E, Karlowsky J, Doern G (2005) Antibiotic resistance in paediatric uropathogens. Int J Antimicrob Agents 26:267–271

    Article  CAS  Google Scholar 

  11. Raymond J, Nordmann P, Doit C, Vu Thien H, Guibert M, Ferroni A, Aujard Y (2007) Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study. Pediatrics 119:e798–e803

    Article  Google Scholar 

  12. Anatoliotaki M, Galanakis E, Schinaki A, Stefanaki S, Mavrokosta M, Tsilimigaki A (2007) Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece. Scand J Infect Dis 39:671–675

    Article  CAS  Google Scholar 

  13. Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F (2006) Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 28:413–416

    Article  Google Scholar 

  14. Lutter SA, Currie ML, Mitz LB, Greenbaum LA (2005) Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med 159:924–928

    Article  Google Scholar 

  15. Prelog M, Schiefecker D, Fille M, Wurzner R, Brunner A, Zimmerhackl LB, Wurzner R, Brunner A, Zimmerhackl LB (2008) Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatr Nephrol 23:597–602

    Article  Google Scholar 

  16. Haller M, Brandis M, Berner R (2004) Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 19:982–986

    Article  Google Scholar 

  17. Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E (2005) Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 115:942–949

    Article  Google Scholar 

  18. Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS (2007) Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629–637

    Article  CAS  Google Scholar 

  19. Huang SS, Lee MH, Leu HS (2006) Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella. J Microbiol Immunol Infect 39:496–502

    CAS  PubMed  Google Scholar 

  20. Kuo KC, Shen YH, Hwang KP (2007) Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan. J Microbiol Immunol Infect 40:248–254

    PubMed  Google Scholar 

  21. Réjiba S, Kechrid A (2007) Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia. J Chemother 19:382–387

    Article  Google Scholar 

  22. Tellevik MG, Sollid JE, Blomberg B, Jureen R, Urassa WK, Langeland N (2007) Extended-spectrum beta-lactamase-type SHV-12-producing Enterobacteriaceae causing septicemia in Tanzanian children: vectors for horizontal transfer of antimicrobial resistance. Diagn Microbiol Infect Dis 59:351–354

    Article  CAS  Google Scholar 

  23. Wadula J, von Gottberg A, Kilner D, de Jong G, Cohen C, Khoosal M, Keddy K, Crewe-Brown H (2006) Nosocomial outbreak of extended-spectrum beta-lactamase-producing Salmonella isangi in pediatric wards. Pediatr Infect Dis J 25:843–844

    Article  CAS  Google Scholar 

  24. Qin X, Zerr DM, Weissman SJ, Englund JA, Denno DM, Klein EJ, Tarr PI, Kwong J, Stapp JR, Tulloch LG, Galanakis E (2008) Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children’s hospital experience. Antimicrob Agents Chemother 11:3909–39014

    Article  Google Scholar 

  25. Delińska-Galińska A, Kurlenda J, Kozielska E, Borkowska A, Luczak G, Plata-Nazar K (2006) Prevalence of ESBL strains in urinary tract infections in children in 1996 and 2004. Przegl Epidemiol 60:59–64

    PubMed  Google Scholar 

  26. Giamarellou H (2005) Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 11:1S4–16S4

    Article  Google Scholar 

  27. Thomson RB Jr (2007) Specimen collection, transport and processing: bacteriology. In: Murray P, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, vol I, 9th edn. American Society for Microbiology, Washington, pp 291–333

    Google Scholar 

  28. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial suspectibility testing: Nineteenth informational supplement. CLSI Document M100-S19. Wayne, PA, USA. Available at http://www.clsi.org/source/orders/free/m100-s19.pdf

  29. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE (1985) International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol 15:105–109

    Article  CAS  Google Scholar 

  30. Christian MT, McColl JH, MacKenzie JR, Tj B (2000) Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography. Arch Dis Child 82:376–380

    Article  CAS  Google Scholar 

  31. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797

    Article  Google Scholar 

  32. Akram M, Shahid M, Khan AU (2007) Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh. India. Ann Clin Microbiol Antimicrob 6:4

    Article  Google Scholar 

  33. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162–1171

    Article  CAS  Google Scholar 

  34. Calbo E, Romani V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum b-lactamases. J Antimicrob Chemother 57:780–783

    Article  CAS  Google Scholar 

  35. Winberg J, Bollgren I, Gothefors L, Herthelius M, Tullus K (1989) The prepuce: a mistake of nature? Lancet 1:598–599

    Article  CAS  Google Scholar 

  36. Singh-Grewal D, Macdessi J, Craig J (2005) Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomized trials and observational studies. Arch Dis Child 90:853–858

    Article  CAS  Google Scholar 

  37. Lescure FX, Eveillard M, Douadi Y, Eb F (2001) Community-acquired multiresistant bacteria: an emerging problem? J Hosp Infec 49:149–151

    Article  CAS  Google Scholar 

  38. Rodriguez-Bano J, Navarro MD, Romero L, Martínez-Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089–1094

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Bitsori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bitsori, M., Maraki, S., Kalmanti, M. et al. Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol 24, 2381–2386 (2009). https://doi.org/10.1007/s00467-009-1255-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-009-1255-1

Keywords

Navigation